INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹-78 Cr | ₹97 Cr | ₹142 Cr | ₹155 Cr | ₹93 Cr |
What is the latest Profit After Tax of INDOCO REMEDIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹-78 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹142 Cr |
| Mar2022 | ₹155 Cr |
| Mar2021 | ₹93 Cr |
How is Profit After Tax of INDOCO REMEDIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹-78 Cr | Negative | |
| Mar2024 | ₹97 Cr | -31.81 | |
| Mar2023 | ₹142 Cr | -8.11 | |
| Mar2022 | ₹155 Cr | 66.37 | |
| Mar2021 | ₹93 Cr | - | |
Compare Profit After Tax of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,334.5 Cr | -6.2% | -10.4% | -15.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -6.2% |
-10.4% |
-15.1% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses